Cord blood could become an off-the-shelf leukaemia therapy

Queensland researchers have secured nearly $4 million to develop CAR-T cell therapy made from donated umbilical cord blood, for older people with acute myeloid leukaemia.

Queensland researchers have secured nearly $4 million to develop CAR-T cell therapy made from donated umbilical cord blood, for older people with acute myeloid leukaemia.